Page last updated: 2024-08-24

dexmedetomidine and Muscular Dystrophy

dexmedetomidine has been researched along with Muscular Dystrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creaney, M; Milner, M; Moriarty, RM; Murphy, C1
Guruli, ZV; Ramadhyani, U; Shukry, M1

Other Studies

2 other study(ies) available for dexmedetomidine and Muscular Dystrophy

ArticleYear
Dexmedetomidine, high-flow nasal oxygen and sugammadex-reversal of rocuronium: overcoming anaesthetic challenges in a parturient with congenital muscular dystrophy presenting for caesarean section.
    International journal of obstetric anesthesia, 2018, Volume: 34

    Topics: Adult; Airway Management; Androstanols; Anesthesia, Epidural; Anesthesia, Obstetrical; Cesarean Section; Dexmedetomidine; Emergency Medical Services; Female; gamma-Cyclodextrins; Humans; Hypnotics and Sedatives; Infant, Newborn; Muscular Dystrophies; Neuromuscular Nondepolarizing Agents; Oxygen Inhalation Therapy; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Rocuronium; Sugammadex

2018
Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent.
    Paediatric anaesthesia, 2006, Volume: 16, Issue:4

    Topics: Anesthesia, Intravenous; Child; Dantrolene; Dexmedetomidine; Humans; Laminin; Male; Malignant Hyperthermia; Muscle Relaxants, Central; Muscular Dystrophies; Phenotype

2006